蛋白质治疗市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00002856
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

蛋白质疗法将精确数量的蛋白质(根据患者的需要)输送到体内,以治疗各种疾病,如糖尿病、贫血、慢性肾功能衰竭或重塑结构。治疗性蛋白质是速效且有效的药物,已被证明在治疗多种疾病方面非常成功。随着对疾病分子机制的了解不断加深,将继续有机会开发蛋白质疗法。自 1982 年推出第一个源自重组 DNA 的人胰岛素蛋白以来,蛋白质治疗领域取得了显着发展。与目前主导医药市场的小分子药物相比,蛋白质具有多种优势。

对蛋白质治疗产品开发的日益关注、重组蛋白质药物的不断创新以及基于抗体的药物的不断增长,导致了对蛋白质治疗产品的研究不断增加。蛋白质工程。治疗性蛋白质和肽也被认为在治疗癌症、神经退行性疾病等各种疾病方面具有巨大潜力。然而,蛋白质的理化不稳定性和免疫原性问题可能会在预测期内抑制全球蛋白质治疗市场。

“到2031年全球蛋白质治疗市场分析”是一项专门且深入的研究生物科技行业,关注全球市场动向。该报告旨在提供全球市场概况,并按产品、应用、最终用户和地理位置进行详细的市场细分。预计全球蛋白质治疗市场在预测期内将出现高速增长。该报告提供了主要蛋白质治疗市场参与者的市场状况的关键统计数据,并提供了市场的主要趋势和机会。

全球蛋白质治疗市场根据产品、应用、终端进行细分用户。根据产品,市场分为单克隆抗体、胰岛素、融合蛋白、促红细胞生成素、干扰素、人类生长激素和卵泡刺激素。蛋白质治疗市场按应用分为代谢紊乱、免疫紊乱、血液紊乱、癌症、激素紊乱、遗传性疾病等。根据最终用户,蛋白质治疗市场分为制药公司、医疗保健服务提供商、研究组织和医疗机构。学术研究机构。

该报告提供了行业的详细概述,包括定性和定量信息。它提供了基于产品、应用和最终用户的全球蛋白质治疗市场的概述和预测。它还提供了五个主要地区的市场规模和到 2031 年整体市场的预测,即:北美、欧洲、亚太地区 (APAC)、中东和非洲 (MEA) 以及南美和非洲中美洲。每个地区的蛋白质治疗市场随后按各自的国家和细分市场进行细分。该报告涵盖了全球13个国家的分析和预测,以及该地区当前的趋势和机遇。

北美在2021年蛋白质治疗市场占据主导份额。主要份额归因于技术进步有利的报销政策、新产品的开发和生活水平的提高导致预期寿命延长,导致老年人口增加。这些因素正在促进该地区蛋白质疗法的增长。
由于糖尿病等慢性病的高患病率,预计亚太地区在预测期内将呈现最高的复合年增长率。此外,亚太地区不断增长的医疗旅游业也是预计在预测期内推动蛋白质治疗市场需求的主要因素。此外,对先进治疗方案的需求不断增长,中国、印度和日本等新兴经济体以及人均收入的增加等因素预计将为亚太地区的市场参与者在预测期内创造增长途径。

报告从需求和供应两个方面分析了影响蛋白质治疗市场的因素,并进一步评估了预测期内影响市场的市场动态,即驱动因素、限制因素、机会和未来趋势。该报告还为所有五个地区提供了详尽的 PEST 分析,即:北美、欧洲、亚太地区、中东和非洲以及南美洲和南美洲中美洲在评估了影响这些地区蛋白质治疗市场的政治、经济、社会和技术因素后。

该报告还包括主要蛋白质治疗公司的概况及其 SWOT 分析和市场策略。此外,该报告还重点关注领先的行业参与者,提供公司简介、提供的组件和服务、过去 3 年的财务信息、过去 5 年的主要发展等信息。蛋白质治疗市场的一些主要参与者包括诺和诺德公司、杨森全球服务有限责任公司(强生服务公司)、安进公司、阿斯利康、百特、勃林格殷格翰国际有限公司、梯瓦制药工业公司有限公司、协和发酵麒麟有限公司、辉瑞公司和罗氏有限公司等。


  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the deliverable formats of the Protein Therapeutics Market report?

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

What are the options available for the customization of this report?

Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

Which are key players in Protein Therapeutics Market?

Key companies in this market are - Novo Nordisk A/S, Janssen Global Services LLC, Johnson & Johnson Services Inc, Amgen Inc, AstraZeneca, Baxter, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd, Kyowa Hakko Kirin Co Ltd, Pfizer Inc

What are future trends in the Protein Therapeutics market?

The Protein Therapeutics Market is expected to witness a shift towards personalised medicine with enormous focus on tailored therapy. Innovative therapeutic proteins, better drug design and advancement in protein engineering would deliver enhanced efficacy, addressing specific patient need and expanding market applications.

What is expected CAGR in the Protein Therapeutics Market?

The market is expected to register a CAGR of 6.5% during 2023-2031

What are factors impacting on the Protein Therapeutics market?

Fueling the growth of the Protein Therapeutics Market is the rising incidence of chronic diseases, and the growing need for biologic therapeutics. Also, the rising demand for protein-based therapies is due to the rising acceptance of biological therapies, global efforts to cure chronic diseases, and scientific advancements in protein engineering and manufacturing.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. Novo Nordisk A/S
2. Janssen Global Services, LLC (Johnson & Johnson Services, Inc.)
3. Amgen Inc.
4. AstraZeneca
5. Baxter
6. Boehringer Ingelheim International GmbH
7. Teva Pharmaceutical Industries Ltd.
8. Kyowa Hakko Kirin Co., Ltd.
9. Pfizer Inc.
10. F. Hoffmann-La Roche Ltd

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.